Modified Si–Jun–Zi–Tang Attenuates Airway Inflammation in a Murine Model of Chronic Asthma by Inhibiting Teff Cells via the mTORC1 Pathway
Background: Modified Si–Jun–Zi–Tang (MSJZT), a multi-herb formulation, is frequently used in traditional Chinese medicine for patients during the remission stage of asthma. However, the pharmacological basis underlying the effects of MSJZT on asthma has yet to be elucidated. This study aims at evalu...
Main Authors: | Hualiang Jin, Cui Cai, Bei Li, Weizhong Jin, Junbo Xia, Limin Wang, Shenglin Ma |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-02-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.00161/full |
Similar Items
-
Liu Jun Zi Tang—A Potential, Multi-Herbal Complementary Therapy for Chemotherapy-Induced Neurotoxicity
by: Chun-Tang Chiou, et al.
Published: (2018-04-01) -
Combination Compositions Composed of l-Glutamine and Si-Jun-Zi-Tang Might Be a Preferable Choice for 5-Fluorouracil-Induced Intestinal Mucositis: An Exploration in a Mouse Model
by: Liping Qu, et al.
Published: (2020-06-01) -
The modulatory properties of Si Jun Zi Tang enhancing anticancer of gefitinib by an integrating approach
by: Chunyu Li, et al.
Published: (2019-03-01) -
mTORC1 and mTORC2 are differentially engaged in the development of laser-induced CNV
by: Jin Young Yang, et al.
Published: (2019-06-01) -
mTORC1 is necessary but mTORC2 and GSK3β are inhibitory for AKT3-induced axon regeneration in the central nervous system
by: Linqing Miao, et al.
Published: (2016-03-01)